NU SKIN ENTERPRISES, INC.
10-Ks and 10-Qs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
|
☑
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2016
|
OR
|
☐
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____________ TO _____________
|
Commission File Number:
001-12421
|
NU SKIN ENTERPRISES, INC.
|
||||
|
(Exact name of registrant as specified in its charter)
|
||||
|
Delaware
|
87-0565309
|
|||
|
(State or other jurisdiction of incorporation or organization)
|
75 WEST CENTER STREET
PROVO, UTAH 84601
|
(IRS Employer Identification No.)
|
||
|
(Address of principal executive offices, including zip code)
|
||||
|
(801) 345-1000
|
||||
|
(Registrant's telephone number, including area code)
|
||||
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
☑
No
☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Date File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes
☑
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule12b-2 of the Exchange Act.
|
Large accelerated filer
☑
|
Accelerated filer
☐
|
|
Non-accelerated filer
☐
(Do not check if a smaller reporting company)
|
Smaller reporting company
☐
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☑
As of July 31, 2016, 55,941,494 shares of the registrant's Class A common stock, $.001 par value per share, were outstanding.
NU SKIN ENTERPRISES, INC.
QUARTERLY REPORT ON FORM 10-Q – SECOND QUARTER 2016
QUARTERLY REPORT ON FORM 10-Q – SECOND QUARTER 2016
TABLE OF CONTENTS
|
Page
|
||||
|
Part I.
|
Financial Information
|
|||
|
Item 1.
|
||||
|
1
|
||||
|
2
|
||||
|
3
|
||||
|
4
|
||||
|
5
|
||||
|
Item 2.
|
17
|
|||
|
Item 3.
|
26
|
|||
|
Item 4.
|
26
|
|||
|
Part II.
|
Other Information
|
|||
|
Item 1.
|
26
|
|||
|
Item 1A.
|
28
|
|||
|
Item 2.
|
29
|
|||
|
Item 3.
|
29
|
|||
|
Item 4.
|
29
|
|||
|
Item 5.
|
29
|
|||
|
Item 6.
|
30
|
|||
|
31
|
||||
In this Quarterly Report on Form 10-Q, references to "dollars" and "$" are to United States ("U.S.") dollars.
Nu Skin, Pharmanex, and ageLOC are our trademarks. The italicized product names used in this Quarterly Report on Form 10-Q are product names and also, in certain cases, our trademarks.
PART I. FINANCIAL INFORMATION
NU SKIN ENTERPRISES, INC.
(U.S. dollars in thousands)
|
June 30,
|
December 31,
|
|||||||
|
2016
|
2015
|
|||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
544,848
|
$
|
289,354
|
||||
|
Current investments
|
11,503
|
14,371
|
||||||
|
Accounts receivable
|
31,706
|
35,464
|
||||||
|
Inventories, net
|
259,933
|
265,256
|
||||||
|
Prepaid expenses and other
|
162,710
|
101,947
|
||||||
|
1,010,700
|
706,392
|
|||||||
|
Property and equipment, net
|
453,342
|
454,537
|
||||||
|
Goodwill
|
114,954
|
112,446
|
||||||
|
Other intangible assets, net
|
67,410
|
67,009
|
||||||
|
Other assets
|
134,463
|
165,459
|
||||||
|
Total assets
|
$
|
1,780,869
|
$
|
1,505,843
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
43,360
|
$
|
28,832
|
||||
|
Accrued expenses
|
350,849
|
310,916
|
||||||
|
Current portion of long-term debt
|
96,896
|
67,849
|
||||||
|
491,105
|
407,597
|
|||||||
|
Long-term debt
|
362,051
|
181,745
|
||||||
|
Other liabilities
|
97,473
|
90,880
|
||||||
|
Total liabilities
|
950,629
|
680,222
|
||||||
|
Commitments and contingencies (Note 9)
|
||||||||
|
Stockholders' equity:
|
||||||||
|
Class A common stock – 500 million shares authorized, $.001 par value, 90.6 million shares issued
|
91
|
91
|
||||||
|
Additional paid-in capital
|
431,459
|
419,921
|
||||||
|
Treasury stock, at cost – 34.6 million shares
|
(1,032,117
|
)
|
(1,017,063
|
)
|
||||
|
Accumulated other comprehensive loss
|
(71,463
|
)
|
(71,269
|
)
|
||||
|
Retained earnings
|
1,502,270
|
1,493,941
|
||||||
|
830,240
|
825,621
|
|||||||
|
Total liabilities and stockholders' equity
|
$
|
1,780,869
|
$
|
1,505,843
|
||||
The accompanying notes are an integral part of these consolidated financial statements.
-1-
NU SKIN ENTERPRISES, INC.
(U.S. dollars in thousands, except per share amounts)
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2016
|
2015
|
2016
|
2015
|
|||||||||||||
|
Revenue
|
$
|
600,475
|
$
|
560,209
|
$
|
1,072,306
|
$
|
1,103,541
|
||||||||
|
Cost of sales
|
128,205
|
110,263
|
266,074
|
215,318
|
||||||||||||
|
Gross profit
|
472,270
|
449,946
|
806,232
|
888,223
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Selling expenses
|
248,363
|
239,449
|
443,922
|
473,454
|
||||||||||||
|
General and administrative expenses
|
144,109
|
138,696
|
274,363
|
274,322
|
||||||||||||
|
Total operating expenses
|
392,472
|
378,145
|
718,285
|
747,776
|
||||||||||||
|
Operating income
|
79,798
|
71,801
|
87,947
|
140,447
|
||||||||||||
|
Other income (expense), net
|
(11,060
|
)
|
(2,758
|
)
|
(13,923
|
)
|
(15,026
|
)
|
||||||||
|
Income before provision for income taxes
|
68,738
|
69,043
|
74,024
|
125,421
|
||||||||||||
|
Provision for income taxes
|
24,025
|
24,386
|
25,995
|
44,482
|
||||||||||||
|
Net income
|
$
|
44,713
|
$
|
44,657
|
$
|
48,029
|
$
|
80,939
|
||||||||
|
Net income per share (Note 2):
|
||||||||||||||||
|
Basic
|
$
|
0.80
|
$
|
0.76
|
$
|
0.86
|
$
|
1.38
|
||||||||
|
Diluted
|
$
|
0.79
|
$
|
0.75
|
$
|
0.85
|
$
|
1.35
|
||||||||
|
Weighted-average common shares
outstanding (000s):
|
||||||||||||||||
|
Basic
|
55,952
|
58,506
|
55,953
|
58,747
|
||||||||||||
|
Diluted
|
56,356
|
59,713
|
56,388
|
59,994
|
||||||||||||
The accompanying notes are an integral part of these consolidated financial statements.
-2-
NU SKIN ENTERPRISES, INC.
(U.S. dollars in thousands)
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2016
|
2015
|
2016
|
2015
|
|||||||||||||
|
Net income
|
$
|
44,713
|
$
|
44,657
|
$
|
48,029
|
$
|
80,939
|
||||||||
|
Other comprehensive income, net of tax:
|
||||||||||||||||
|
Foreign currency translation adjustment, net of taxes of $886 and $629 for the three months ended June 30, 2016 and 2015, respectively, and $(1,565) and $(5,824) for the six months ended June 30, 2016 and 2015, respectively
|
(3,639
|
)
|
(676
|
)
|
1,950
|
(10,726
|
)
|
|||||||||
|
Net unrealized gains/(losses) on foreign currency cash flow hedges, net of taxes of $645 and $51 for the three months ended June 30, 2016 and 2015, respectively, and 1,575 and $(170) for the six months ended June 30, 2016 and 2015, respectively
|
(1,170
|
)
|
(93
|
)
|
(2,860
|
)
|
309
|
|||||||||
|
Reclassification adjustment for realized losses/(gains) in current earnings, net of taxes of $(329) and $279 for the three months ended June 30, 2016 and 2015, respectively, and $(395) and $723 for the six months ended June 30, 2016 and 2015, respectively
|
597
|
(506
|
)
|
716
|
(1,313
|
)
|
||||||||||
|
(4,212
|
)
|
(1,275
|
)
|
(194
|
)
|
(11,730
|
)
|
|||||||||
|
Comprehensive income
|
$
|
40,501
|
$
|
43,382
|
$
|
47,835
|
$
|
69,209
|
||||||||
The accompanying notes are an integral part of these consolidated financial statements.
-3-
NU SKIN ENTERPRISES, INC.
(U.S. dollars in thousands)
|
Six Months Ended
|
||||||||
|
June 30,
|
||||||||
|
2016
|
2015
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
48,029
|
$
|
80,939
|
||||
|
Adjustments to reconcile net income to net cash
|
||||||||
|
provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
34,684
|
34,101
|
||||||
|
Japan customs expense
|
31,355
|
−
|
||||||
|
Foreign currency losses
|
13,519
|
13,811
|
||||||
|
Stock-based compensation
|
7,586
|
7,424
|
||||||
|
Deferred taxes
|
2,463
|
7,001
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
4,595
|
(8,493
|
)
|
|||||
|
Inventories, net
|
6,871
|
27,709
|
||||||
|
Prepaid expenses and other
|
(62,091
|
)
|
11,333
|
|||||
|
Other assets
|
12
|
(16,500
|
)
|
|||||
|
Accounts payable
|
14,353
|
5,112
|
||||||
|
Accrued expenses
|
36,486
|
4,910
|
||||||
|
Other liabilities
|
(2,037
|
)
|
(7,745
|
)
|
||||
|
Net cash provided by operating activities
|
135,825
|
159,602
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property and equipment
|
(24,714
|
)
|
(34,842
|
)
|
||||
|
Proceeds of investment sales
|
10,881
|
8,155
|
||||||
|
Purchases of investments
|
(9,869
|
)
|
(8,155
|
)
|
||||
|
Acquisitions
|
(4,400
|
)
|
−
|
|||||
|
Net cash used in investing activities
|
(28,102
|
)
|
(34,842
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Exercise of employee stock options
|
2,777
|
(1,039
|
)
|
|||||
|
Payment of debt
|
(18,978
|
)
|
(14,556
|
)
|
||||
|
Payment of cash dividends
|
(39,698
|
)
|
(41,179
|
)
|
||||
|
Income tax benefit of options exercised
|
3,520
|
3,195
|
||||||
|
Proceeds from debt
|
233,721
|
20,000
|
||||||
|
Payment of debt issuance costs
|
(6,596
|
)
|
−
|
|||||
|
Repurchases of shares of common stock
|
(24,296
|
)
|
(75,862
|
)
|
||||
|
Net cash provided by (used in) financing activities
|
150,450
|
(109,441
|
)
|
|||||
|
Effect of exchange rate changes on cash
|
(2,679
|
)
|
(11,320
|
)
|
||||
|
Net increase in cash and cash equivalents
|
255,494
|
3,999
|
||||||
|
Cash and cash equivalents, beginning of period
|
289,354
|
288,415
|
||||||
|
Cash and cash equivalents, end of period
|
$
|
544,848
|
$
|
292,414
|
||||
The accompanying notes are an integral part of these consolidated financial statements.
-4-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
Nu Skin Enterprises, Inc. (the "Company") is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last several years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC anti-aging brand. The Company reports revenue from five geographic regions: Greater China, which consists of Mainland China, Hong Kong, Macau and Taiwan; North Asia, which consists of Japan and South Korea; Americas, which consists of the United States, Canada and Latin America; South Asia/Pacific, which consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; and Europe, Middle East and Africa ("EMEA"), which consists of several markets in Europe as well as Israel, Russia, Ukraine and South Africa (the Company's subsidiaries operating in these countries in each region are collectively referred to as the "Subsidiaries").
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information as of June 30, 2016, and for the three- and six-month periods ended June 30, 2016 and 2015. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. The consolidated balance sheet as of December 31, 2015 has been prepared using information from the audited financial statements at that date. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2015.
2.
NET INCOME PER SHARE
Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended June 30, 2016 and 2015, stock options of 2.8 million and 1.5 million, respectively, and for the six-month periods ended June 30, 2016 and 2015, stock options of 3.1 million and 1.5 million, respectively, were excluded from the calculation of diluted earnings per share because they were anti-dilutive.
3.
DIVIDENDS PER SHARE
In January and April 2016, the Company's board of directors declared a quarterly cash dividend of $0.355 per share. These quarterly cash dividends of $19.8 million and $19.9 million were paid on March 16, 2016 and June 8, 2016 to stockholders of record on February 26, 2016 and May 27, 2016. In July 2016, the Company's board of directors declared a quarterly cash dividend of $0.355 per share to be paid on September 14, 2016 to stockholders of record on August 26, 2016.
-5-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
4.
DERIVATIVE FINANCIAL INSTRUMENTS
As of June 30, 2016, the Company held mark-to-market forward derivative contracts to hedge foreign denominated intercompany positions with notional amounts of 500.0 million Japanese yen ($4.8 million) and 11.5 billion Korean won ($10.0 million), 3.9 million Canadian dollars ($3.0 million) and 16.0 million South African rand ($1.1 million) with related gains and losses being recorded as part of Other Income (Expense); in addition, the Company held mark-to-market forward contracts designated as foreign currency cash flow hedges with notional amounts totaling 2.9 billion Japanese yen and 9.0 million euros ($28.1 million and $10.0 million, respectively) as of June 30, 2016 and 1.3 billion Japanese yen and 15.0 million euros ($10.6 million and $13.5 million, respectively) as of June 30, 2015 to hedge forecasted foreign-currency-denominated intercompany transactions. The fair value of these hedges were $0.1 million and $(3.3) million as of June 30, 2015 and 2016, respectively.
The contracts held at June 30, 2016 have maturities through June 2017, and accordingly, all unrealized gains and losses on foreign currency cash flow hedges included in accumulated other comprehensive loss will be recognized in current earnings over the next 12 months. The pre-tax net gains/(losses) on foreign currency cash flow hedges reclassified from accumulated other comprehensive loss to the income statement were $(0.9) million and $0.8 million, respectively, for the three-month periods ended June 30, 2016 and 2015 and $(1.1) million and $2.0 million, respectively, for the six-month periods ended June 30, 2016 and 2015. The corresponding tax effects of these transactions were recorded in provision for income tax expense. As of June 30, 2016 and December 31, 2015, there were $(1.9) million and $0.3 million, respectively, of unrealized gains/(losses) included in accumulated other comprehensive loss related to foreign currency cash flow hedges. The remaining $69.6 million and $71.6 million as of June 30, 2016 and December 31, 2015, respectively, in accumulated other comprehensive loss are related to cumulative translation adjustments.
5.
REPURCHASES OF COMMON STOCK
During the three-month periods ended June 30, 2016 and 2015, the Company repurchased 0.1 million and 0.9 million shares of its Class A common stock under its open market stock repurchase plans for $4.3 million and $49.6 million, respectively. During the six-month periods ended June 30, 2016 and 2015, the Company repurchased 0.7 million and 1.4 million shares of its Class A common stock under its open market repurchase plans for $24.3 million and $75.9 million, respectively. As of June 30, 2016, $422.7 million was available for repurchases under the Company's open market stock repurchase plan.
6.
SEGMENT INFORMATION
The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China. In Mainland China, the Company utilizes sales employees, independent direct sellers and independent marketers to distribute its products. While sales employees sell products through the Company's stores and website, independent direct sellers can sell away from the Company's stores where the Company has obtained a direct selling license to do so. Independent marketers are licensed business owners who are authorized to sell the Company's products either at their own approved premises or through the Company's stores. Selling expenses are the Company's largest expense comprised of sales compensation and incentives paid to its sales force. The Company manages its business primarily by managing its sales force. The Company does not use profitability reports on a regional or divisional basis for making business decisions. However, the Company does report revenue in five geographic regions: Greater China, North Asia, Americas, South Asia/Pacific and EMEA.
-6-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
Revenue:
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Greater China
|
$
|
236,716
|
$
|
200,136
|
$
|
395,427
|
$
|
387,503
|
||||||||
|
North Asia
|
165,885
|
172,943
|
317,094
|
345,009
|
||||||||||||
|
Americas
|
67,884
|
83,468
|
133,632
|
163,340
|
||||||||||||
|
South Asia/Pacific
|
92,297
|
68,023
|
155,875
|
138,840
|
||||||||||||
|
EMEA
|
37,693
|
35,639
|
70,278
|
68,849
|
||||||||||||
|
Totals
|
$
|
600,475
|
$
|
560,209
|
$
|
1,072,306
|
$
|
1,103,541
|
||||||||
Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
Revenue:
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Nu Skin
|
$
|
365,266
|
$
|
351,436
|
$
|
655,255
|
$
|
694,202
|
||||||||
|
Pharmanex
|
234,014
|
207,504
|
414,728
|
406,776
|
||||||||||||
|
Other
|
1,195
|
1,269
|
2,323
|
2,563
|
||||||||||||
|
Totals
|
$
|
600,475
|
$
|
560,209
|
$
|
1,072,306
|
$
|
1,103,541
|
||||||||
Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
Revenue:
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Mainland China
|
$
|
184,344
|
$
|
149,251
|
$
|
302,999
|
$
|
283,448
|
||||||||
|
South Korea
|
93,036
|
109,023
|
179,154
|
217,800
|
||||||||||||
|
Japan
|
72,849
|
63,920
|
137,940
|
127,209
|
||||||||||||
|
United States
|
50,028
|
58,580
|
97,261
|
117,568
|
||||||||||||
|
Long-lived assets:
|
June 30,
2016
|
December 31,
2015
|
||||||
|
Mainland China
|
$
|
104,319
|
$
|
110,839
|
||||
|
South Korea
|
46,449
|
48,702
|
||||||
|
Japan
|
14,592
|
13,587
|
||||||
|
United States
|
276,931
|
271,057
|
||||||
7.
DEFERRED TAX ASSETS AND LIABILITIES
The Company accounts for income taxes in accordance with ASC 740 Income Taxes Topic of the Financial Accounting Standards Codification. These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise's activities during the current and preceding years. The Company takes an asset and liability approach for financial accounting and reporting of income taxes. The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates. Deferred tax assets and liabilities are created in this process. The Company has netted these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized. As of June 30, 2016 and December 31, 2015, the Company had net deferred tax assets of $20.2 million and $24.2 million, respectively.
-7-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter. Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal and state income taxes applicable to the earnings. For all foreign earnings, the Company accrues the applicable foreign income taxes. The Company intends to utilize the offshore earnings to fund foreign investments, specifically capital expenditures. Undistributed earnings that the Company has indefinitely reinvested, for which no federal or state income taxes in the U.S. have been provided, aggregate to $70.0 million as of December 31, 2015. If the amount designated as indefinitely reinvested as of December 31, 2015 was repatriated to the United States, the amount of incremental taxes would be approximately $3.4 million.
8.
UNCERTAIN TAX POSITIONS
The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. The Company is no longer subject to tax examinations from the IRS for all years for which tax returns have been filed before 2011. With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2011. In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process ("CAP"). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return. The Company has elected to participate in the CAP program for 2016 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time. In major foreign jurisdictions, the Company is generally no longer subject to income tax examinations for years before 2010. However, statutes in certain countries may be as long as ten years for transfer pricing related issues. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable.
The Company's unrecognized tax benefits relate to multiple foreign and domestic jurisdictions. Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company's gross unrecognized tax benefits, net of foreign currency adjustments, may increase within the next 12 months by a range of approximately $0.1 million to $1.0 million.
9.
COMMITMENTS AND CONTINGENCIES
The Company is subject to government regulations pertaining to product formulation, labeling and packaging, product claims and advertising, and the Company's direct selling system. The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities. Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could have a material adverse effect on the Company's operations. In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations. Although management believes that the Company is in compliance in all material respects with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position or results of operations or cash flows. The Company and its Subsidiaries are defendants in litigation and proceedings involving various matters. Except as noted below, in the opinion of the Company's management, based upon advice of its counsel handling such litigation and proceedings, adverse outcomes, if any, will not likely result in a material effect on the Company's consolidated financial condition, results of operations or cash flows
.
-8-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
The Company is subject to regular audits by federal, state and foreign tax authorities. These audits may result in additional tax liabilities. The Company believes it has appropriately provided for income taxes for all years. Several factors drive the calculation of its tax reserves. Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results.
10.
DEBT
On October 9, 2014, the Company entered into a Credit Agreement (the "Credit Agreement") with various financial institutions, and Bank of America, N.A. as administrative agent. The Credit Agreement provides for a $127.5 million term loan facility, a 6.6 billion Japanese yen term loan facility and a $187.5 million revolving credit facility, each with a term of five years. On October 10, 2014, the Company drew the full amount of the term loan facilities, and as of June 30, 2016 and December 31, 2015, the Company had outstanding balances of $62.5 million and $47.5 million on the revolving credit facility. Any additional amounts drawn under the revolving credit facility will bear interest at rates that will be determined in accordance with the Credit Agreement. The Credit Agreement requires that the Company maintain a consolidated leverage ratio not exceeding 2.00 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. The Company believes these covenants provide it with greater flexibility to pay dividends and repurchase stock. The Company is in compliance with its debt covenants.
The following table summarizes the Company's debt facilities as of December 31, 2015 and June 30, 2016:
|
Facility or
Arrangement
|
Original
Principal Amount
|
Balance as of
December 31, 2015
|
Balance as of
June 30, 2016
(1)(2)
|
Interest Rate
|
Repayment terms
|
|||||
|
Credit Agreement term loan facility:
|
||||||||||
|
U.S. dollar
denominated:
|
$127.5 million
|
$118.7 million
|
$113.9 million
|
Variable 30 day: 2.7045%
|
One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.
|
|||||
|
Japanese yen
denominated:
|
6.6 billion yen
|
6.1 billion yen ($51.1 million as of December 31, 2015)
|
5.9 billion yen ($57.1 million as of June 30, 2016)
|
Variable 30 day: 2.25%
|
One half of the principal amount payable in increasing quarterly installments over a five-year period that began on December 31, 2014, with the remainder payable at the end of the five-year term.
|
|||||
|
Credit Agreement revolving credit facility:
|
||||||||||
|
$47.5 million
|
$62.5 million
|
Variable 30 day: 2.7045%
|
Revolving line of credit expires October 2019.
|
|||||||
|
Korea subsidiary loan:
|
||||||||||
|
$20.0 million
|
$20.0 million
|
$20.0 million
|
1.12%
|
One half of the principal amount payable on March 17, 2017 and the remainder payable on March 16, 2018.
|
||||||
|
Japan subsidiary loan:
|
||||||||||
|
2.0 billion yen
|
2.0 billion yen ($16.6 million as of December 31, 2015)
|
1.7 billion yen ($16.2 million as of June 30, 2016)
|
0.66%
|
Payable in semi-annual installments over three years that began on January 31, 2016.
|
||||||
|
Convertible note
(3)
|
||||||||||
|
$210.0 million
|
-
|
$210.0 million
|
4.75%
|
Principal amount payable on June 15, 2020.
|
||||||
| (1) | As of June 30, 2016, the current portion of the Company's debt (i.e. becoming due in the next 12 months) included $74.5 million of the balance of its U.S. dollar-denominated debt under the Credit Agreement term loan facility, $6.0 million of the balance of its Japanese yen-denominated debt under the Credit Agreement term loan facility, $10.0 million of the Korea subsidiary loan and $6.5 million of the Japan subsidiary loan. The Company has classified the amount borrowed under the Credit Agreement revolving credit facility as short term because it is the Company's intention to use this line of credit to borrow and pay back funds over short periods of time. |
| (2) | The carrying value of the debt reflects the amounts stated in the above table less a debt discount of $3.7 million on the credit agreement and $17.0 million on the convertible debt, which is not reflected in this table. |
| (3) | See Note 11 for more information regarding the convertible note. |
-9-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
11.
CONVERTIBLE NOTE
On June 16, 2016, the Company issued $210.0 million of convertible senior notes (the "Convertible Notes") in a private offering to a Chinese investor (the "Holder"). The Convertible Notes are senior unsecured obligations which will rank equal in right of payment to all senior unsecured indebtedness of the Company, and will rank senior in right of payment to any indebtedness that is contractually subordinated to the Convertible Notes. Interest on the Convertible Notes is payable semiannually in arrears on June 15 and December 15 of each year, beginning on December 15, 2016 at a rate of 4.75% per annum.
The Convertible Notes mature on June 15, 2020, unless repurchased or converted prior to maturity. Prior to the stated maturity date, the Company may, at its option, redeem all or part of the Convertible Notes at a price equal to 100% of the principal amount thereof, plus accrued and unpaid interest, if any, provided that its common stock share price is equal to or exceeds 180% of the applicable conversion price for 20 or more trading days (including the final three trading days) in the 30 consecutive trading days prior to the Company's exercise of such redemption right. The Holder of the Convertible Notes may, at its option, cause the Company to repurchase all of such Holder's Convertible Notes or any portion thereof that is equal to $1,000 in principal amount or multiples of $1,000 upon a change in control or a termination of trading of the Company's common stock, as those terms are defined in the indenture governing the Convertible Notes. In addition, each holder of the Convertible Notes shall have the right, at such holder's option, to convert all or any portion thereof that is equal to $1,000 in principal amount or multiples of $1,000 at any time beginning six calendar months following June 16, 2016, at the then-applicable conversion rate. Upon conversion by the Holder, the Convertible Notes will be settled in cash with respect to principal and any accrued and unpaid interest to such date and in the Company's common shares with respect to any additional amounts, based on the applicable conversion rate at such time. The Convertible Notes had an initial conversion rate of 21.5054 common shares per $1,000 principal amount of the Convertible Notes (which is equal to an initial conversion price of approximately $46.50 per common share). Throughout the term of the Convertible Notes, the conversion rate may be adjusted upon the occurrence of certain specified events.
Of the $210.0 million in proceeds received from the issuance of the Convertible Notes, $199.1 million was allocated to long-term debt (the "Liability Component") and $10.9 million was allocated to additional paid-in-capital (the "Equity Component") within the Company's consolidated balance sheet. The Liability Component was calculated by measuring the fair value of a similar debt instrument that does not have an associated conversion feature. The amount allocated to the Equity Component, which represents the conversion option, was calculated by deducting the fair value of the Liability Component from the par value of the Convertible Notes. The Company determined that the conversion option does not require separate accounting treatment as a derivative instrument because it is both indexed to the Company's own stock and would be classified in stockholder's equity if freestanding. The Equity Component will not be remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the Liability Component over its carrying amount (the "Debt Discount") will be amortized to interest expense over the term of the Convertible Notes. As a result, the Liability Component will be accreted up to the Convertible Notes' $210.0 million face value, resulting in additional non-cash interest expense being recognized within the Company's consolidated statement of income. The effective interest rate on the Convertible Notes is approximately 7.1% per annum.
-10-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
|
June 30,
2016
|
||||
|
Principal
|
$
|
210,000
|
||
|
Unamortized debt discount (conversion option)
|
(10,828
|
)
|
||
|
Total long-term debt, net
|
199,172
|
|||
|
Unamortized debt discount (issuance costs)
|
(6,196
|
)
|
||
|
Net carrying amount
|
$
|
192,976
|
||
The net carrying amount of the Liability Component was recorded to long-term debt within the Company's consolidated balance sheet.
The Company incurred approximately $6.6 million of issuance costs related to the issuance of the Convertible Notes. Of the $6.6 million in issuance costs incurred, $6.3 million and $0.3 million were recorded to deferred financing cost and additional paid-in capital, respectively, in proportion to the allocation of the proceeds of the Convertible Notes. The $6.3 million recorded to deferred financing cost on the Company's consolidated balance sheet as a reduction of long-term debt is being amortized over the contractual term of the Convertible Notes using the effective interest method.
During the quarter ended June 30, 2016, the Company recognized $0.6 million in non-cash interest expense related to the Convertible Notes, which included $0.4 million of contractual interest and $0.2 million in amortization of debt issuance costs and in amortization of the Debt Discount.
As the Convertible Notes were issued in June 2016, the carrying value of the Convertible Notes approximates their fair value at June 30, 2016.
12.
ACCOUNTING PRONOUNCEMENTS
In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-08,
Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.
This ASU changes the threshold for a disposal to qualify as a discontinued operation. To be considered a discontinued operation, a disposal now must represent a strategic shift that has or will have a major effect on an entity's operations and financial results. This ASU also requires new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation. This update will be applied prospectively and was effective for annual periods, and interim periods within those years, beginning after December 15, 2014. The adoption of this standard did not have a material impact on the Company's financial statements.
In May 2014, the FASB issued ASU No. 2014-09,
Revenue from Contracts with Customers (Topic 606)
. The new revenue recognition standard provides a five-step analysis of transactions to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU is effective for annual periods beginning after December 15, 2017 and shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is evaluating the potential impact of this adoption on its consolidated financial statements.
-11-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
In June 2014, the FASB issued ASU No. 2014-12,
Compensation—Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force)
. This ASU clarifies that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in Topic 718 as it relates to awards with performance conditions that affect vesting to account for such awards. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. This ASU is effective for annual periods, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted. This ASU may be applied either (a) prospectively to all awards granted or modified after the effective date or (b) retrospectively to all awards with performance targets that are outstanding as of the beginning of the earliest annual period presented in the financial statements and to all new or modified awards thereafter. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.
In August 2014, the FASB issued ASU No. 2014-15,
Presentation of Financial Statements — Going Concern (Subtopic 205-40).
The purpose of this ASU is to incorporate into U.S. GAAP management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern within one year after the date that the financial statements are issued, and to provide related footnote disclosures. This update is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.
In April 2015, the FASB issued ASU 2015-03,
Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs
. This guidance requires that debt issuance costs be presented as a direct reduction to the carrying amount of the related debt in the balance sheet rather than as a deferred charge, consistent with the presentation of discounts on debt. ASU 2015-15,
Interest - Imputation of Interest (Subtopic 835-30): Presentation and Subsequent Measurement of Debt Issuance Costs associated with Line-of-Credit Arrangements
, was issued in August 2015 to clarify that the U.S. Securities and Exchange Commission ("SEC") staff would not object to an entity deferring and presenting debt issuance costs related to a line-of-credit arrangement as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. The guidance is effective for fiscal years beginning after December 15, 2015, and is to be applied retrospectively. Early adoption is permitted. The adoption of this guidance did not have a material impact on the Company's consolidated financial statements.
In July 2015, the FASB issued ASU 2015-11,
Inventory (Topic 330): Simplifying the Measurement of Inventory
. This guidance requires an entity to measure inventory at the lower of cost and net realizable value, rather than at the lower of cost or market. The guidance is effective for interim and annual periods beginning after December 15, 2016, and is to be applied prospectively. Early adoption is permitted. The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02,
Leases (Subtopic 842)
. ASU 2016-02 will require companies to recognize lease assets and lease liabilities on the balance sheet and disclose key information about leasing arrangements. For public companies, this standard is effective for annual reporting periods beginning after December 15, 2018, and early adoption is permitted. The Company is currently evaluating the impact of this standard on its consolidated financial position, results of operations, and cash flows.
-12-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
In March 2016, the FASB issued ASU 2016-09,
Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting
. The objective of this update is to simplify several aspects of the accounting for employee share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. This ASU is effective for fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the new guidance to determine the impact it may have on its consolidated financial statements.
13.
COST OF SALES
In February 2016, the Tokyo District Court issued its ruling on a dispute between the Company and the customs authorities in Japan. The District Court upheld previous customs assessments related to the importation of several of the Company's products into Japan.
As a result of the District Court's decision, the Company recorded a charge of $31.4 million to cost of sales in the first quarter of 2016. This is a non-cash item because the Company was previously required to pay the assessments. This charge represents the full amount that was disputed, including assessments for the period of October 2006 through September 2009 in connection with post-importation audits, as well as the disputed portion of the Company's import duties from October 2009 to the date of the District Court's decision. The Company has appealed this decision to the Tokyo High Court.
14.
CLASS ACTION SETTLEMENT
On February 22, 2016, the Company entered into a Settlement Term Sheet (the "Agreement") in potential settlement of the previously reported putative securities class action consolidated lawsuit. The litigation was brought against the Company and certain of the Company's officers (collectively, the "Defendants") on behalf of a class consisting of persons or entities that publicly traded the Company's common stock during the period from May 4, 2011 through January 17, 2014 and were allegedly damaged thereby. In May 2016, the court issued preliminary approval of the settlement.
-13-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
The terms of the Agreement provide for, among other things, a settlement payment by, or on behalf of, the Company of $47 million, which the Company recorded as a short-term liability in its consolidated balance sheet. As expected, the Company's insurers fully funded the settlement payment in an escrow account in June 2016, and the Company maintained the corresponding amount as a short-term receivable, which it had recorded during the first quarter of 2016. There was no net impact on the Company's consolidated statement of income.
The settlement remains subject to court approval and may be cancelled by the Defendants at their sole election in certain limited circumstances. A hearing for final court approval of the settlement is scheduled in October 2016, but could be delayed by circumstances beyond the Company's control. Subsequent to final approval of the settlement by the court, the litigation will be dismissed, with prejudice.
15.
ACQUISITION
In the first quarter of 2016, the Company purchased 70% of Vertical Eden, LLC, an early-stage company in the warehouse growing market, based in Alpine, Utah, for $3.3 million in cash and contingent consideration valued at $1.5 million. The purchase of Vertical Eden includes specialized technology in remote programming and management of the entire crop growing cycle. As a result of this acquisition, the Company has recorded approximately $4.4 million of intangible assets which will be amortized over the useful lives of 3 to 7 years. The Company has also recorded $2.5 million of goodwill. Due to the insignificance of the transaction to the Company's consolidated financial statements, the Company has not separately presented the $2.1 million non-controlling interest related to this acquisition, but has included it in additional paid-in capital and has included the net income (loss) attributable to the non-controlling interest in other income (expense).
-14-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
16.
ADDITIONAL QUARTERLY DISCLOSURES
Inventory
Inventories consist of the following (U.S. dollars in thousands):
|
June 30,
2016
|
December 31,
2015
|
|||||||
|
Raw materials
|
$
|
126,663
|
$
|
114,193
|
||||
|
Finished goods
|
133,270
|
151,063
|
||||||
|
$
|
259,933
|
$
|
265,256
|
|||||
Fair Value
The following tables present the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis (U.S. dollars in thousands):
|
Fair Value at June 30, 2016
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Financial assets (liabilities):
|
||||||||||||||||
|
Cash equivalents and current investments
|
$
|
190,811
|
$
|
−
|
$
|
−
|
$
|
190,811
|
||||||||
|
Forward contracts
|
−
|
(3,317
|
)
|
−
|
(3,317
|
)
|
||||||||||
|
Life insurance contracts
|
−
|
−
|
28,754
|
28,754
|
||||||||||||
|
Total
|
$
|
190,811
|
$
|
(3,317
|
)
|
$
|
28,754
|
$
|
216,248
|
|||||||
|
Fair Value at December 31, 2015
|
||||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
|||||||||||||
|
Financial assets (liabilities):
|
||||||||||||||||
|
Cash equivalents and current investments
|
$
|
47,121
|
$
|
−
|
$
|
−
|
$
|
47,121
|
||||||||
|
Forward contracts
|
−
|
485
|
−
|
485
|
||||||||||||
|
Life insurance contracts
|
−
|
−
|
27,292
|
27,292
|
||||||||||||
|
Total
|
$
|
47,121
|
$
|
485
|
$
|
27,292
|
$
|
74,898
|
||||||||
-15-
NU SKIN ENTERPRISES, INC.
Notes to Consolidated Financial Statements
The following table provides a summary of changes in fair value of the Company's Level 3 marketable securities (U.S. dollars in thousands):
|
Life Insurance Contracts
|
||||
|
Beginning balance at January 1, 2016
|
$
|
27,292
|
||
|
Actual return on plan assets:
|
||||
|
Relating to assets still held at the reporting date
|
810
|
|||
|
Purchases and issuances
|
780
|
|||
|
Sales and settlements
|
(128
|
)
|
||
|
Transfers into Level 3
|
-
|
|||
|
Ending balance at June 30, 2016
|
$
|
28,754
|
||
-16-
ITEM 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION
AND RESULTS OF OPERATIONS
This quarterly report on Form 10-Q (this "Quarterly Report") contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent our current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding our performance, initiatives, strategies, product introductions and offerings, growth, opportunities and risks; statements of projections regarding future sales, expenses, operating results, taxes and duties, capital expenditures, sources and uses of cash, foreign currency fluctuations or devaluations, and other financial items; statements of management's expectations and beliefs regarding our markets; statements regarding the payment of future dividends and stock repurchases; statements regarding the outcome of litigation, audits or investigations; accounting estimates and assumptions; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. We caution and advise readers that these statements are based on assumptions that may not be realized and involve risks and uncertainties that could cause actual results to differ materially from the expectations and beliefs contained herein. For a summary of these risks, see the risk factors included in our Annual Report on Form 10-K for the year ended December 31, 2015 and in subsequent Quarterly Reports on Form 10-Q (our "Periodic Reports"), as well as our Current Reports on Form 8-K.
The following Management's Discussion and Analysis should be read in conjunction with our consolidated financial statements and related notes and Management's Discussion and Analysis included in our Periodic Reports, and our other filings, including Current Reports on Form 8-K, filed with the Securities and Exchange Commission through the date of this report.
Overview
Revenue for the three-month period ended June 30, 2016 increased 7% to $600.5 million, compared to the prior-year period, and revenue for the six-month period ended June 30, 2016 decreased 3% to $1.1 billion, compared to the prior-year period. Foreign currency fluctuations negatively impacted revenue 3% and 4% in the three- and six-month periods ended June 30, 2016, respectively, compared to the prior-year periods. We currently expect that the stronger U.S. dollar will continue to impact our results in 2016. Revenue for the second quarter of 2016 includes approximately $106 million of sales generated from limited-time offers in our Greater China and South Asia/Pacific regions during the quarter. We did not have any limited-time offers during the first half of 2015. Sales Leaders and Actives for the quarter were up 6% and flat, respectively, compared to the prior-year quarter.
Earnings per share for the second quarter of 2016 were $0.79, compared to $0.75 in the prior-year period. This increase primarily reflects the increase in revenue, partially offset by foreign currency translation expenses of $11.1 million in the second quarter of 2016. For more information on these expenses, see "Other income (expense), net," below.
Earnings per share for the first half of 2016 were $0.85, or $1.21 excluding a non-cash expense of $31.4 million in the first quarter of 2016 associated with the Japan customs ruling that is discussed in Note 13 to the consolidated financial statements contained in this report, compared to $1.35 for the first half of 2015. Excluding the Japan customs expense, earnings per share for the six-month period decreased due largely to the decline in revenue. Earnings per share excluding Japan customs expense is a non-GAAP financial measure. See "Non-GAAP Financial Measures," below.
-17-
We expect that our revenue for the remainder of 2016 will be positively impacted by the continued rollout of our
ageLOC Me
personalized skin care system and our
ageLOC Youth
nutritional supplement throughout the remainder of the year.
Revenue
Greater China
. The following table sets forth revenue for the three- and six-month periods ended June 30, 2016 and 2015 for the Greater China region and its principal markets (U.S. dollars in millions):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2016
|
2015
|
Change
|
2016
|
2015
|
Change
|
|||||||||||||||||||
|
Mainland China
|
$
|
184.3
|
$
|
149.2
|
24
|
%
|
$
|
303.0
|
$
|
283.4
|
7
|
%
|
||||||||||||
|
Taiwan/Hong Kong
|
52.4
|
50.9
|
3
|
%
|
92.4
|
104.1
|
(11
|
%)
|
||||||||||||||||
|
Greater China total
|
$
|
236.7
|
$
|
200.1
|
18
|
%
|
$
|
395.4
|
$
|
387.5
|
2
|
%
|
||||||||||||
Foreign currency fluctuations negatively impacted revenue 6% and 5% in this region for the three- and six-month periods ended June 30, 2016, respectively, compared to the prior-year periods. Sales Leaders and Actives in Mainland China increased 33% and 38%, respectively, compared to the prior-year quarter. Sales Leaders and Actives in Taiwan were down 14% and 7%, respectively, and in Hong Kong they were down 14% and 13%, respectively, compared to the prior-year quarter.
The year-over-year revenue increase for the second quarter of 2016 reflects approximately $72 million in revenue generated by a limited-time offer of
ageLOC Me
in the region. The results of this limited-time offer were strong, particularly in Mainland China. The year-over-year revenue results for the six-month period ended June 30, 2016 were tempered by the region's results for the first quarter of 2016. As previously disclosed, revenue in the region for the first quarter of 2016 was negatively impacted by declines in Sales Leaders and Actives in the region, particularly in Taiwan and Hong Kong. Although Taiwan and Hong Kong benefited from the limited-time offer during the second quarter of 2016, we continue to see softness in these markets.
We currently plan to launch an air purifier product in this region
later this year
, and we plan to make
ageLOC Me
generally available for purchase in this region near the end of 2016 or the beginning of 2017.
North Asia
. The following table sets forth revenue for the three- and six-month periods ended June 30, 2016 and 2015 for the North Asia region and its principal markets (U.S. dollars in millions):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2016
|
2015
|
Change
|
2016
|
2015
|
Change
|
|||||||||||||||||||
|
South Korea
|
$
|
93.0
|
$
|
109.0
|
(15
|
%)
|
$
|
179.2
|
$
|
217.8
|
(18
|
%)
|
||||||||||||
|
Japan
|
72.9
|
63.9
|
14
|
%
|
137.9
|
127.2
|
8
|
%
|
||||||||||||||||
|
North Asia total
|
$
|
165.9
|
$
|
172.9
|
(4
|
%)
|
$
|
317.1
|
$
|
345.0
|
(8
|
%)
|
||||||||||||
Revenue in the North Asia region for the three- and six-month periods ended June 30, 2016 was positively impacted 2% and negatively impacted 1%, respectively, by foreign currency fluctuations, compared to the prior-year periods.
In South Korea, foreign currency fluctuations negatively impacted revenue 5% and 6% for the second quarter of 2016 and first half of 2016, respectively, compared to the prior-year periods. In the second quarter of 2016, Sales Leaders and Actives in South Korea each decreased 8%, compared to the prior-year period. We believe the declines in revenue, Sales Leaders and Actives for the three- and six-month periods reflected softness in the South Korea market. During the third quarter of 2016, in July, we had a successful introduction of
ageLOC Youth
in a limited-time offer in South Korea.
-18-
In Japan, year-over-year reported revenue growth of 14% and 8% for the second quarter of 2016 and the first half of 2016, respectively, reflects a positive impact of approximately 13% and 8%, respectively, from the strengthening of the Japanese yen against the U.S. dollar, compared to the prior-year periods. Local-currency revenue in Japan grew 1% in the second quarter of 2016 and was approximately even in the first half of 2016, compared to the prior-year periods. In the second quarter of 2016, Sales Leaders and Actives in Japan decreased 1% and 8%, respectively, compared to the prior-year period. The regulatory environment in Japan continues to be challenging. We made
ageLOC Me
generally available for purchase in Japan during the second quarter of 2016, and we currently plan to make
ageLOC Youth
generally available for purchase in Japan during the fourth quarter of 2016.
Americas
. The following table sets forth revenue for the three- and six-month periods ended June 30, 2016 and 2015 for the Americas region and its principal markets (U.S. dollars in millions):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2016
|
2015
|
Change
|
2016
|
2015
|
Change
|
|||||||||||||||||||
|
United States/Canada
|
$
|
60.4
|
$
|
68.6
|
(12
|
%)
|
$
|
117.8
|
$
|
137.2
|
(14
|
%)
|
||||||||||||
|
Latin America
|
7.5
|
14.9
|
(50
|
%)
|
15.8
|
26.1
|
(39
|
%)
|
||||||||||||||||
|
Americas total
|
$
|
67.9
|
$
|
83.5
|
(19
|
%)
|
$
|
133.6
|
$
|
163.3
|
(18
|
%)
|
||||||||||||
Revenue in the Americas region for the three- and six-month periods ended June 30, 2016 was negatively impacted 4% and 5% by foreign currency fluctuations, respectively, compared to the prior-year periods. Sales Leaders and Actives in the region declined 17% and 8%, respectively, in the second quarter of 2016, compared to the prior-year period. These declines in revenue, Sales Leaders and Actives reflect steep declines in Latin America, primarily in Venezuela, as well as continued weakness in the United States, where revenue was down 15% and 17% for the second quarter and first half of 2016, respectively, compared to the prior-year periods.
We currently plan to offer
ageLOC Me
in this region during the fourth quarter of 2016.
South Asia/Pacific
. The following table sets forth revenue for the three- and six-month periods ended June 30, 2016 and 2015 for the South Asia/Pacific region (U.S. dollars in millions):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2016
|
2015
|
Change
|
2016
|
2015
|
Change
|
|||||||||||||||||||
|
South Asia/Pacific
|
$
|
92.3
|
$
|
68.0
|
36
|
%
|
$
|
155.9
|
$
|
138.8
|
12
|
%
|
||||||||||||
Year-over-year revenue growth in the South Asia/Pacific region for the three- and six-month periods ended June 30, 2016 was 36% and 12%, respectively, despite negative impacts from foreign currency of 6% and 7%, respectively. In the second quarter of 2016, Sales Leaders in the region increased 6% and Actives decreased 5%, compared to the prior-year period. We generated strong revenue growth across the markets in this region during the second quarter of 2016, driven by a limited-time offer of
ageLOC Youth
, which generated approximately $35 million in sales in the region. There were no limited-time offer sales in this region during the second quarter of the prior year.
We anticipate difficult year-over-year comparisons in this region in the third quarter of 2016, as a limited-time offer in the third quarter of 2015 generated approximately $47 million in sales in the region. We do not have any significant product initiatives scheduled in this region in the third quarter of 2016. In the fourth quarter of 2016, we currently plan to make
ageLOC Youth
generally available for purchase in the region.
-19-
EMEA . The following table sets forth revenue for the three- and six-month periods ended June 30, 2016 and 2015 for the Europe, Middle East and Africa ("EMEA") region (U.S. dollars in millions):
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||||||||||
|
2016
|
2015
|
Change
|
2016
|
2015
|
Change
|
|||||||||||||||||||
|
EMEA
|
$
|
37.7
|
$
|
35.6
|
6
|
%
|
$
|
70.3
|
$
|
68.8
|
2
|
%
|
||||||||||||
Revenue in the EMEA region for the three- and six-month periods ended June 30, 2016 was positively impacted 1% and negatively impacted 1%, respectively, by foreign currency fluctuations, compared to the prior-year periods. In the second quarter of 2016, Sales Leaders and Actives in the region increased 3% and 6%, compared to the prior-year period. Revenue growth in the region reflects the continued success of Sales Leader social media initiatives in certain markets.
Gross profit
Gross profit as a percentage of revenue was 78.7% and 75.2% for the three- and six-month periods ended June 30, 2016 and 80.3% and 80.5% for the three- and six-month periods ended June 30, 2015. The year-over-year decrease in the second quarter was primarily driven by promotions of
ageLOC Me
in the second quarter of 2016 and continued strength of the U.S. dollar. The year-over-year decrease for the six-month period was primarily driven by the non-cash Japan customs expense of $31.4 million in the first quarter of 2016 that is discussed in Note 13 to the consolidated financial statements contained in this report. Excluding this expense, gross profit as a percentage of revenue for the first half of 2016 was 78.1%. Gross profit excluding Japan customs expense is a non-GAAP financial measure. See "Non-GAAP Financial Measures," below.
Selling expenses
Selling expenses as a percentage of revenue decreased to 41.4% for the three-month period ended June 30, 2016 from 42.7% for the same period in 2015. Selling expenses as a percentage of revenue decreased to 41.4% for the six-month period ended June 30, 2016 from 42.9% for the same period in 2015. The salaries of our sales employees in Mainland China are fixed for a three-month period of time, until they are adjusted during a quarterly evaluation process. Selling expenses as a percentage of revenue in the first half of 2016 were also lower due to a reduction in the number of Sales Leaders qualifying for incentive trips and other promotional incentives in the first half of 2016.
General and administrative expenses
General and administrative expenses increased to $144.1 million in the second quarter of 2016 and $274.4 in the first half of 2016, compared to $138.7 million and $274.3 in the respective prior-year periods. The increase in the second quarter of 2016 primarily reflects increased labor expenses and increased expenses related to events and other promotions. As a percentage of revenue, general and administrative expenses decreased to 24.0% and increased to 25.6% for the three- and six-month periods ended June 30, 2016, respectively, from 24.8% and 24.9% for the same periods in 2015, reflecting fluctuations in revenue and relatively stable general and administrative expenses.
Other income (expense), net
Other income (expense), net for the three- and six-month periods ended June 30, 2016 was $11.1 million of expense and $13.9 million of expense, respectively, compared to $2.8 million of expense and $15.0 million of expense for the same periods in 2015. The second-quarter year-over-year increase in expense reflects foreign currency translation expenses of $11.1 million in the second quarter of 2016, primarily driven by translation expenses resulting from the strengthening of the Japanese yen against the U.S. dollar and its impact on our Japanese yen-denominated debt and liabilities. The year-over-year comparison for the first half of 2016 also reflects a $10.2 million foreign currency charge in the first quarter of 2015 resulting from the impact of the devaluation of the Venezuelan currency on the monetary assets and liabilities of our Venezuela entity. This devaluation resulted from a foreign exchange mechanism that Venezuela announced in the first quarter of 2015.
-20-
Provision for income taxes
Provision for income taxes for the three- and six-month periods ended June 30, 2016 was $24.0 million and $26.0 million, compared to $24.4 million and $44.5 million for the same periods in 2015. The effective tax rate was 35.0% and 35.1%, of pre-tax income during the three- and six-month periods ended June 30, 2016, respectively, compared to 35.3% and 35.5%, respectively, in the prior-year periods.
Net income
As a result of the foregoing factors, net income for the second quarter of 2016 was $44.7 million, which is unchanged from the same period in 2015. Net income for the first half of 2016 was $48.0 million, or $68.1 million excluding Japan customs expense of $31.4 million ($20.1 million, net of tax), compared to $80.9 million for the first half of 2015. Net income excluding Japan customs expense is a non-GAAP financial measure. See "Non-GAAP Financial Measures" below.
Liquidity and Capital Resources
Historically, our principal uses of cash have included operating expenses, particularly selling expenses, and working capital (principally inventory purchases), as well as capital expenditures, stock repurchases, dividends, debt repayment and the development of operations in new markets. We have at times incurred long-term debt in order to fund strategic transactions and stock repurchases. We typically generate positive cash flow from operations due to favorable margins and have generally relied on cash from operations to fund operating activities. We generated $135.8 million in cash from operations during the first half of 2016, compared to $159.6 million in cash generated from operations during the prior-year period. This decrease in cash generated from operations during the first half of 2016 reflects payments made during the first quarter of 2016, primarily (1) the payment of a significant amount of items that were accrued as of the end of 2015, particularly commissions based on limited-time offers during December 2015; and (2) payments to build up inventory for planned product launches in 2016. In the second quarter of 2016, we generated $138.6 million in cash from operations.
As of June 30, 2016, working capital was $519.6 million, compared to $298.8 million as of December 31, 2015. Cash and cash equivalents, including current investments, as of June 30, 2016 and December 31, 2015 were $556.4 million and $303.7 million, respectively.
Capital expenditures in the first half of 2016 were $24.7 million, and we anticipate additional capital expenditures of approximately $30 million for the remainder of 2016. Our 2016 capital expenditures are primarily related to:
| • | the expansion and upgrade of facilities in our various markets; and |
| • | purchases and expenditures for computer systems and equipment, software, and application development. |
On June 16, 2016, we issued $210.0 million principal amount of convertible 4.75% senior notes, due 2020 (the "Convertible Notes") to Ping An ZQ China Growth Opportunity Limited ("Ping An ZQ") at face value. Net proceeds on the issuance of the Convertible Notes were $203 million. We plan to use the proceeds primarily for repurchasing common stock throughout the remainder of the year. The Convertible Notes are senior unsecured obligations of the Company and rank equal in right of payment to all senior unsecured indebtedness of the Company. Interest on the Convertible Notes is payable semiannually in cash on June 15 and December 15, and the Convertible Notes mature on June 15, 2020, subject to earlier conversion. Although the stated interest rate on the Convertible Notes is 4.75%, interest on this debt is expensed on our income statement at a rate of approximately 7.1%, reflecting the amortization of a debt discount resulting from approximately $6.3 million in issuance costs and approximately $10.9 million of the principal amount that is allocated to equity due to the conversion option. Beginning December 16, 2016, the Convertible Notes will be convertible at the holder's discretion at a conversion rate of 21.5054 per $1,000 principal amount of Convertible Notes (which represents an initial conversion price of $46.50 per share), in each case subject to customary anti-dilution adjustments. As of August 3, 2016, the conversion price remained at $46.50 per share. So long as the Convertible Notes are held by Ping An ZQ, any conversion of the Convertible Notes will be satisfied by cash in respect of the principal amount of Convertible Notes converted and any accrued and unpaid interest to such date, and shares of our common stock in respect to all additional amounts. Conversion of Convertible Notes by any other holders may be into cash, common stock or a combination of cash and common stock, at our option.
-21-
Upon a change in control of the Company (as defined in the indenture governing the Convertible Notes) or the failure of our common stock to be listed on certain stock exchanges, the holders of the Convertible Notes may require that we repurchase all or part of the principal amount of the Convertible Notes at a purchase price equal to 108% of the principal amount plus accrued and unpaid interest. In addition, we may redeem all or part of the principal amount of the Convertible Notes, at our option, at a purchase price equal to the principal amount plus accrued and unpaid interest, provided that the closing trading price of our common stock exceeds 180% of the then-current conversion price for 20 or more trading days in the 30 consecutive trading day period preceding our exercise of this redemption right (including the last three such trading days). The Convertible Notes are subject to customary events of default, which may result in the acceleration of the maturity of the Convertible Notes.
Our Credit Agreement (the "Credit Agreement") with various financial institutions, and Bank of America, N.A. as administrative agent, provides for a $127.5 million term loan facility, a 6.6 billion Japanese yen term loan facility and a $187.5 million revolving credit facility, each with a term of five years ending in October 2019. The Credit Agreement requires that we maintain a consolidated leverage ratio not exceeding 2.00 to 1.00 and a consolidated interest coverage ratio of no less than 3.00 to 1.00. As of June 30, 2016, we had debt pursuant to the Credit Agreement of $233.5 million. See Notes 10 and 11 to the consolidated financial statements contained in this report for further information regarding the Credit Agreement, Convertible Notes and other debt.
Our board of directors has approved a stock repurchase plan authorizing us to repurchase up to $500 million of our outstanding shares of Class A common stock on the open market or in private transactions. The repurchases are used primarily for strategic initiatives and to offset dilution from our equity incentive plans and from conversion of the Convertible Notes. During the first half of 2016, we repurchased 0.7 million shares of Class A common stock under this plan for $24.3 million. As of June 30, 2016, $422.7 million was available for repurchases under the stock repurchase plan.
In January and April 2016, our board of directors declared a quarterly cash dividend of $0.355 per share. These quarterly cash dividends of $19.8 million and $19.9 million were paid on March 16, 2016 and June 8, 2016 to stockholders of record on February 26, 2016 and May 27, 2016. In July 2016, our board of directors declared a quarterly cash dividend of $0.355 per share to be paid on September 14, 2016 to stockholders of record on August 26, 2016.
Currently, we anticipate that our board of directors will continue to declare quarterly cash dividends and that the cash flows from operations will be sufficient to fund our future dividend payments. However, the continued declaration of dividends is subject to the discretion of our board of directors and will depend upon various factors, including our net earnings, financial condition, cash requirements, future prospects and other relevant factors.
As of June 30, 2016 and December 31, 2015, we held $556.4 million and $303.7 million, respectively, in cash and cash equivalents, including current investments. As of June 30, 2016 and December 31, 2015, cash and cash equivalents includes $300.3 million and $241.4 million, respectively, held in our operations outside of the U.S. Substantially all of our non-U.S. cash and cash equivalents are readily convertible into U.S. dollars or other currencies, with the exception of cash in Venezuela, which is subject to currency exchange restrictions by the government of Venezuela.
As of June 30, 2016, we had $1.7 million in monetary assets denominated in Venezuela bolivars.
-22-
We typically fund the cash requirements of our operations in the U.S. through intercompany dividends and intercompany charges for products, use of intangible property, and corporate services. Some markets impose government-approval or other requirements for the repatriation of dividends. For example, in Mainland China, we are unable to repatriate cash from current operations in the form of dividends until we file the necessary statutory financial statements for the relevant period. As of June 30, 2016, we had $139.5 million in cash denominated in Chinese RMB. We also have intercompany loan arrangements with some of our markets, including Mainland China, that allow us to access available cash. We currently plan to repatriate undistributed earnings from our non-U.S. operations as necessary, considering the cash needs of our non-U.S. operations and the cash needs of our U.S. operations for dividends, stock repurchases, capital investments, debt repayment and strategic transactions. Except for partial indefinite reinvestment in two jurisdictions, we have not designated our investments as indefinitely reinvested, but rather have these funds available for our operations in the U.S. as needed. Any repatriation of non-U.S. earnings requires payment of U.S. taxes in accordance with applicable U.S. tax rules and regulations. Accordingly, we have accrued the necessary U.S. taxes related to the funds that are not indefinitely reinvested.
We currently believe that existing cash balances, future cash flows from operations and existing lines of credit will be adequate to fund our cash needs on both a short- and long-term basis. The majority of our historical expenses have been variable in nature and as such, a potential reduction in the level of revenue would reduce our cash flow needs. In the event that our current cash balances, future cash flow from operations and current lines of credit are not sufficient to meet our obligations or strategic needs, we would consider raising additional funds in the debt or equity markets or restructuring our current debt obligations. Additionally, we would consider realigning our strategic plans, including a reduction in capital spending, stock repurchases or dividend payments.
Contingent Liabilities
Please refer to Note 9 to the consolidated financial statements contained in this report for information regarding our contingent liabilities.
Critical Accounting Policies
There were no significant changes in our critical accounting policies during the quarter ended June 30, 2016.
Seasonality and Cyclicality
In addition to general economic factors, we are impacted by seasonal factors and trends such as major cultural events and vacation patterns. For example, most Asian markets celebrate their respective local New Year in the first quarter, which generally has a negative impact on that quarter. We believe that direct selling is also generally negatively impacted during the third quarter, when many individuals, including our sales force, traditionally take vacations.
Although our product launch process may vary by market, we generally introduce new key products to our sales force and consumers through limited-time offers. The limited-time offers typically generate significant activity and a high level of purchasing, which often results in a higher-than-normal increase in revenue during the quarter of the limited-time offer and skew year-over-year and sequential comparisons.
-23-
Actives and Sales Leaders
The following table provides information concerning the number of Actives and Sales Leaders as of the dates indicated. "Actives" are persons who have purchased products directly from the Company during the three months ended as of the date indicated. "Sales Leaders" are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.
|
As of June 30, 2016
|
As of June 30, 2015
|
|||||||||||||||
|
Region:
|
Actives
|
Sales Leaders
|
Actives
|
Sales Leaders
|
||||||||||||
|
Greater China
|
257,000
|
31,554
|
215,000
|
25,956
|
||||||||||||
|
North Asia
|
356,000
|
16,128
|
387,000
|
16,991
|
||||||||||||
|
Americas
|
165,000
|
6,515
|
180,000
|
7,892
|
||||||||||||
|
South Asia/Pacific
|
113,000
|
7,747
|
120,000
|
7,279
|
||||||||||||
|
EMEA
|
121,000
|
4,168
|
113,000
|
4,042
|
||||||||||||
|
Total
|
1,012,000
|
66,112
|
1,015,000
|
62,160
|
||||||||||||
Currency Risk and Exchange Rate Information
A majority of our revenue and many of our expenses are recognized outside of the United States, except for inventory purchases, a significant portion of which are primarily transacted in U.S. dollars from vendors in the United States. The local currency of each of our Subsidiaries' primary markets is considered the functional currency with the exception of our Asia product-distribution subsidiary in Singapore and our Venezuela subsidiary. All revenue and expenses are translated at weighted-average exchange rates for the periods reported. Therefore, our reported revenue and earnings will be positively impacted by a weakening of the U.S. dollar and will be negatively impacted by a strengthening of the U.S. dollar. Given the large portion of our business derived from outside of the United States, any strengthening of the U.S. dollar negatively impacts reported revenue and profits, whereas a weakening of the U.S. dollar positively impacts our reported revenue and profits. Given the uncertainty of exchange rate fluctuations, it is difficult to predict the effect of these fluctuations on our future business, product pricing and results of operations or financial condition. During 2014 and 2015, the strengthening of the U.S. dollar against other currencies significantly impacted our financial results.
Additionally, we may seek to reduce our exposure to fluctuations in foreign currency exchange rates through the use of foreign currency exchange contracts and through intercompany loans of foreign currency. We do not use derivative financial instruments for trading or speculative purposes. We regularly monitor our foreign currency risks and periodically take measures to reduce the impact of foreign exchange fluctuations on our operating results. As of June 30, 2016, we held mark-to-market forward derivative contracts to hedge foreign denominated intercompany positions or third-party foreign debt with notional amounts of 500.0 million Japanese yen ($4.8 million) and 11.5 billion Korean won ($10.0 million), 3.9 million Canadian dollars ($3.0 million) and 16.0 million South African rand ($1.1 million) with related gains and losses being recorded as part of Other Income (Expense); in addition, we held forward contracts designated as foreign currency cash flow hedges with notional amounts totaling approximately 2.9 billion Japanese yen and 9.0 million euros ($28.1 million and $10.0 million, respectively, as of June 30, 2016) to hedge forecasted foreign-currency-denominated intercompany transactions. At June 30, 2015, we held forward contracts designated as foreign currency cash flow hedges with notional amounts totaling approximately 1.3 billion Japanese yen ($10.6 million as of June 30, 2015) and 15.0 million euros ($13.5 million as of June 30, 2015). Because of our foreign exchange contracts at June 30, 2016, the impact of a 10% appreciation or 10% depreciation of the U.S. dollar against the Japanese yen, the Korean won or the euro would not represent a material potential loss in fair value, earnings or cash flows against these contracts. This potential loss does not consider the underlying foreign currency transaction or translation exposures to which we are subject.
-24-
Available Information
Our website address is www.nuskinenterprises.com. We make available free of charge on the Investor Relations portion of our website, ir.nuskin.com, our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission.
We also use the Investor Relations portion of our website at ir.nuskin.com as a channel of distribution of additional Company information that may be deemed material. Accordingly, investors should monitor this channel, in addition to following our press releases, Securities and Exchange Commission filings and public conference calls and webcasts. The contents of our website shall not be deemed to be incorporated herein by reference.
Non-GAAP Financial Measures
Regulation G, Conditions for Use of Non-GAAP Financial Measures, and other SEC regulations define and prescribe the conditions for use of certain non-GAAP financial information. Our measures of earnings per share, gross profit and net income, each excluding the Japan customs expense, meet the definition of non-GAAP financial measures. Earnings per share, gross profit and net income, each excluding the Japan customs expense, are used in addition to and in conjunction with results presented in accordance with GAAP and should not be relied upon to the exclusion of GAAP financial measures.
Management believes these non-GAAP financial measures assist management and investors in evaluating, and comparing from period to period, results from ongoing operations in a more meaningful and consistent manner while also highlighting more meaningful trends in the results of operations.
The following is a reconciliation of gross profit, as reported, to gross profit excluding Japan customs expenses for the six months ended June 30, 2016 and 2015 (U.S. dollars in thousands):
|
Six Months Ended
June 30,
|
||||||||
|
2016
|
2015
|
|||||||
|
Revenue
|
$
|
1,072,306
|
$
|
1,103,541
|
||||
|
Gross profit
|
$
|
806,232
|
$
|
888,223
|
||||
|
Japan customs expense
|
31,355
|
—
|
||||||
|
Gross profit, excluding Japan customs expense
|
$
|
837,587
|
$
|
888,223
|
||||
|
Gross profit as a % of revenue
|
75.2
|
%
|
80.5
|
%
|
||||
|
Gross profit, excluding Japan customs expense, as a % of revenue
|
78.1
|
%
|
||||||
-25-
The following is a reconciliation of net income, as reported, to net income excluding Japan customs expenses and diluted earnings per share, as reported, to diluted earnings per share excluding Japan customs expenses for the six months ended June 30, 2016 and 2015 (U.S. dollars in thousands):
|
Six Months Ended
June 30,
|
||||||||
|
2016
|
2015
|
|||||||
|
Net income
|
$
|
48,029
|
$
|
80,939
|
||||
|
Japan customs expense
|
31,355
|
—
|
||||||
|
Tax effect of Japan customs expense
|
(11,257
|
)
|
—
|
|||||
|
Net income, excluding Japan customs expense
|
$
|
68,127
|
$
|
80,939
|
||||
|
Diluted earnings per share
|
$
|
0.85
|
$
|
1.35
|
||||
|
Diluted earnings per share, excluding Japan customs expense
|
$
|
1.21
|
||||||
The information required by Item 3 of Part I of Form 10-Q is incorporated herein by reference from the section entitled "Currency Risk and Exchange Rate Information" in "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" of Part I and also from Note 4 to the consolidated financial statements contained in this report.
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")). Based on that evaluation, our CEO and our CFO concluded that our disclosure controls and procedures were effective as of June 30, 2016.
Changes in Internal Controls Over Financial Reporting.
We made no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the fiscal quarter ended June 30, 2016 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II. OTHER INFORMATION
The following information supplements and amends our discussion set forth under "Legal Proceedings" in our Annual Report on Form 10-K for the year ended December 31, 2015 and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2016. Except as discussed below, there have been no material developments concerning the matters discussed in those reports.
As previously disclosed, we are currently being sued in a purported class action lawsuit relating to negative media and regulatory scrutiny regarding our business in Mainland China and the associated decline in our stock price. Beginning in January 2014, six purported class action complaints were filed in the United States District Court for the District of Utah. In May 2014, the court consolidated the various purported class actions, appointed State-Boston Retirement System as lead plaintiff in the consolidated action and appointed the law firm Labaton Sucharow as lead counsel for the purported class in the consolidated action. In June 2014, a consolidated class action complaint was filed. In February 2015, the court denied our motion to dismiss the case. The consolidated class action complaint purports to assert claims on behalf of certain of our stockholders under Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder against Nu Skin Enterprises, Ritch N. Wood, and M. Truman Hunt and to assert claims under Section 20(a) of the Securities Exchange Act of 1934 against Messrs. Wood and Hunt. The consolidated class action complaint alleges that, inter alia, we made materially false and misleading statements regarding our sales operations in and financial results derived from Mainland China, including purportedly operating a pyramid scheme based on illegal multi-level marketing activities. On February 22, 2016, the parties entered into a Settlement Term Sheet (the "Agreement"). The terms of the Agreement provide for, among other things, the certification of a settlement class consisting of persons or entities that publicly traded our common stock during the period from May 4, 2011 through January 17, 2014 and a settlement payment by, or on behalf of, Nu Skin Enterprises, Inc. of $47 million. In May 2016, the court issued preliminary approval of the settlement. In June 2016, our insurers fully funded the settlement payment in an escrow account. The settlement remains subject to final court approval and may be cancelled by us at our sole election in certain limited circumstances. A hearing for final court approval of the settlement is scheduled in October 2016 but could be delayed by circumstances beyond our control. Subsequent to final approval of the settlement by the court, the litigation will be dismissed, with prejudice.
-26-
In addition, beginning in February 2014, five purported shareholder derivative complaints were filed in the United States District Court for the District of Utah. In May 2014, the court issued an order consolidating the derivative actions, appointing plaintiffs Amos C. Acoff and Analisa Suderov as co-lead plaintiffs in the consolidated action, and appointing the law firms Bernstein Litowitz Berger & Grossmann LLP and The Weiser Law Firm, P.C. as co-lead counsel for the plaintiffs in the consolidated action. In July 2014, a consolidated derivative complaint was filed. The consolidated derivative complaint purports to assert claims on behalf of Nu Skin Enterprises, Inc. for, inter alia, breach of fiduciary duties for disseminating false and misleading information, failing to maintain adequate internal controls, unjust enrichment, abuse of control, and gross mismanagement against M. Truman Hunt, Ritch N. Wood, Steven J. Lund, Nevin N. Andersen, Neil H. Offen, Daniel W. Campbell, Andrew W. Lipman, Patricia A. Negrón, Thomas R. Pisano, and nominally against Nu Skin Enterprises, Inc. The consolidated derivative complaint also purports to assert claims on behalf of Nu Skin Enterprises, Inc. for breach of fiduciary duty for insider selling and misappropriation of information against Messrs. Wood, Lund and Campbell. The consolidated derivative complaint alleges that, inter alia, the defendants allowed materially false and misleading statements to be made regarding their sales operations in and financial results derived from Mainland China, including purportedly operating a pyramid scheme based on illegal multi-level marketing activities, and that certain defendants sold common stock on the basis of material, adverse non-public information. In July 2015, the court stayed the derivative action pending a final resolution in the class action lawsuit and denied the Company's motion to dismiss without prejudice to renewing the motion when the stay is lifted. The parties reached a settlement of the matter, and the court issued preliminary approval of the settlement agreement in July 2016. The settlement agreement requires us to implement certain corporate governance measures, and it requires us and/or our insurers to pay or cause to be paid to Plaintiffs' counsel attorneys' fees and expenses in the total amount of $1.3 million. We currently anticipate that our insurers will pay approximately $1.0 million of this amount. The settlement agreement remains subject to final approval by the court.
From time to time, we are involved in legal proceedings arising in the ordinary course of business. We believe that the resolution of these matters will not have a negative material effect on our consolidated financial position, results of operations or liquidity.
Please refer to Notes 9, 13 and 14 to the consolidated financial statements contained in this report and to our recent SEC filings, including our Annual Report on Form 10-K for the 2015 fiscal year and our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2016, for additional information regarding our legal proceedings.
-27-
The information presented below supplements and should be read in conjunction with the detailed discussion of risks associated with our business in our recent SEC filings, including our Annual Report on Form 10-K for the 2015 fiscal year.
Currency exchange rate fluctuations could impact our financial results.
In 2015, approximately 89% of our sales occurred in markets outside of the United States in each market's respective local currency. We purchase inventory primarily in the United States in U.S. dollars. In preparing our financial statements, we translate revenue and expenses in our markets outside the United States from their local currencies into U.S. dollars using weighted average exchange rates. If the U.S. dollar strengthens relative to local currencies, our reported revenue, gross profit and net income will likely be reduced. For example, foreign currency fluctuations negatively impacted reported revenue by approximately 8% in 2015 compared to 2014 and by approximately 3% in 2014 compared to 2013.
Foreign currency fluctuations can also result in losses and gains resulting from translation of foreign currency denominated balances on our balance sheet. Although we may engage in transactions intended to reduce our exposure to foreign currency fluctuations, there can be no assurance that these transactions will be effective. Complex global political and economic dynamics can affect exchange rate fluctuations. For example, significant foreign currency fluctuations occurred as a result of the June 2016 referendum in the United Kingdom, in which voters approved an exit from the European Union. It is difficult to predict future fluctuations and the effect these fluctuations may have upon future reported results or our overall financial condition.
Challenges to the form of our network marketing system could harm our business.
We may be subject to challenges by government regulators regarding the form of our network marketing system. Legal and regulatory requirements concerning the direct-selling industry generally do not include "bright line" rules and are inherently fact-based and subject to interpretation. As a result, regulators and courts have discretion in their application of these laws and regulations, and the enforcement or interpretation of these laws and regulations by government agencies or courts can change. We are aware of ongoing investigations and legal actions against other companies in the direct selling industry. An adverse ruling in these investigations or legal actions could impact our business if direct selling laws or anti-pyramid laws are interpreted more narrowly or in a manner that results in additional burdens or restrictions on direct selling companies. For example, in 2015, the FTC took aggressive actions against a multi-level marketing company, alleging an illegal business model and improper earnings claims. In 2016, the FTC entered into a settlement with another multi-level marketing company, requiring that company to modify its business model. This settlement is not judicial precedent or a new FTC rule, but if it ultimately leads to new industry standards or new rules, our business could be impacted and we may need to amend our distributor compensation plan.
We could also be subject to challenges by private parties in civil actions. We are aware of recent civil actions against some of our competitors in the United States, which have and may in the future result in significant settlements. Allegations by short sellers directed at us and our competitors regarding the legality of multi-level marketing in various markets have also created intense public scrutiny of us and our industry. Our business has also been subject to such formal and informal inquiries from various government regulatory authorities in the past regarding our business and our compliance with local laws and regulations. All of these actions and any future government scrutiny of us or our industry could generate negative publicity or further regulatory actions that could result in fines, restrict our ability to conduct our business in our various markets, enter into new markets, motivate our sales force and attract consumers.
-28-
Purchases of Equity Securities by the Issuer
|
(a)
|
(b)
|
(c)
|
(d)
|
||||||||||||
|
Period
|
Total Number
of Shares Purchased
|
Average Price
Paid per Share
|
Total Number of Shares Purchased
as Part of Publicly Announced
Plans or Programs
|
Approximate Dollar Value of
Shares that May Yet Be Purchased
Under the Plans or Programs
(in millions)
(1)
|
|||||||||||
|
April 1 – 30, 2016
|
79,899
|
$
|
38.73
|
79,899
|
$
|
423.9
|
|||||||||
|
May 1 – 31, 2016
|
31,045
|
$
|
38.53
|
31,045
|
$
|
422.7
|
|||||||||
|
June 1 – 30, 2016
|
-
|
-
|
$
|
422.7
|
|||||||||||
|
Total
|
110,944
|
110,944
|
|||||||||||||
| (1) | In October 2015, we announced that our board of directors approved a stock repurchase plan. Under this plan, our board of directors authorized the repurchase of up to $500.0 million of our outstanding Class A common stock on the open market or in privately negotiated transactions. |
None.
Not Applicable.
None.
-29-
Exhibits
Regulation S-K
Number
Description
| 4.1 | Indenture, dated as of June 16, 2016, by and between Nu Skin Enterprises, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (including the form of 4.75% Convertible Senior Notes Due 2020) (incorporated by reference to Exhibit 4.1 to the Company's Current Report on Form 8-K filed June 21, 2016). |
| 10.1 | Second Amended and Restated 2010 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed May 24, 2016). |
| 10.2 | Investment Agreement, by and among Nu Skin Enterprises, Inc. and Ping An ZQ China Growth Opportunity Limited, dated as of June 14, 2016. |
| 31.1 | Certification by M. Truman Hunt, President and Chief Executive Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2 | Certification by Ritch N. Wood, Chief Financial Officer, pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1 | Certification by M. Truman Hunt, President and Chief Executive Officer, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 32.2 | Certification by Ritch N. Wood, Chief Financial Officer, pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS | XBRL Instance Document |
| 101.SCH | XBRL Taxonomy Extension Schema Document |
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document |
-30-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
August 4, 2016
NU SKIN ENTERPRISES, INC.
|
By:
|
/s/ Ritch N. Wood
|
|
|
|
Ritch N. Wood
|
|
| Chief Financial Officer | ||
| (Duly Authorized Officer and Principal Financial and Accounting Officer) |
-
-31-
TABLE OF CONTENTS
Part I. Financial InformationItem 1. Financial StatementsItem 2. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3. Quantitative and Qualitative Disclosures About Market RiskItem 4. Controls and ProceduresPart II. Other InformationItem 1. Legal ProceedingsItem 1A. Risk FactorsItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3. Defaults Upon Senior SecuritiesItem 4. Mine Safety DisclosuresItem 5. Other InformationItem 6. Exhibits